← Eichor
Study identifier: NCT06231654 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of Remote Photoplethysmography to Assist Vital Signs Measure in Pediatrics

Condition: Using Remote Photoplethysmography for Physiological Parameters  ·  Sponsor: Fondation Lenval

PhaseNA
Planned participants600
Who can joinAll sexes, 3 Years to 17 Years
Healthy volunteersNo

About this study

Introduced in 1930, photoplethysmography techniques presented the possibility of measuring SpO2 and heart rates (HR) using the absorption of light by the blood to define these signals. In recent years, a new approach to photoplethysmography to measure physiological parameters without contact has been developed. This technique, called remote Photoplethysmography Imaging (rPPG), uses the different Red - Green - Blue color spectra at a skin captured by the camera video to determine a plethysmography signal. However, it has never been studied in pediatric patients. The objective is to evaluate the remote photoplethysmography technology to measure vital signs in pediatrics

This description comes directly from the study's public registry record.

Talk to the study team

Antoine TRAN, MCU-MD  ·  04-92-03-04-42  ·  antoine.tran@hpu.lenval.com

Marco OLLA, MD  ·  04-92-03-04-42  ·  marco.olla@hpu.lenval.com

Always discuss trial participation with your own doctor first.

Locations (1)

Fondation Lenval - Hôpitaux Pédiatriques de Nice CHU-LENVALNice, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06231654